Literature DB >> 8222907

Levo-praziquantel versus praziquantel in experimental and clinical treatment of schistosomiasis japonica.

Y H Liu1, M X Qian, X G Wang, Y Z Quan, S H Yan, B Y Chen, J S Li, Z Y Qiu.   

Abstract

Levo-praziquantel is the left isomer of racemic praziquantel. Animal experiments showed that it is an active component of schistosomicidal activity, while dextro-praziquantel is almost ineffective. Clinical trials in three endemic areas of Schistosomiasis japonica indicated that the therapeutic efficacy of levo-praziquantel is superior to racemic praziquantel. Pharmacokinetic and pharmacodynamic activities of the stereoselectivity of praziquantel isomers (enantiomers) are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8222907

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  4 in total

1.  Metabolic profiling of praziquantel enantiomers.

Authors:  Haina Wang; Zhong-Ze Fang; Yang Zheng; Kun Zhou; Changyan Hu; Kristopher W Krausz; Dequn Sun; Jeffrey R Idle; Frank J Gonzalez
Journal:  Biochem Pharmacol       Date:  2014-05-10       Impact factor: 5.858

Review 2.  A research agenda for helminth diseases of humans: intervention for control and elimination.

Authors:  Roger K Prichard; María-Gloria Basáñez; Boakye A Boatin; James S McCarthy; Héctor H García; Guo-Jing Yang; Banchob Sripa; Sara Lustigman
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24

3.  Taste, a new incentive to switch to (R)-praziquantel in schistosomiasis treatment.

Authors:  Thorsten Meyer; Harald Sekljic; Stefan Fuchs; Heiko Bothe; Dieter Schollmeyer; Christian Miculka
Journal:  PLoS Negl Trop Dis       Date:  2009-01-13

4.  Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy.

Authors:  Amaya L Bustinduy; David Waterhouse; Jose C de Sousa-Figueiredo; Stephen A Roberts; Aaron Atuhaire; Govert J Van Dam; Paul L A M Corstjens; Janet T Scott; Michelle C Stanton; Narcis B Kabatereine; Stephen Ward; William W Hope; J Russell Stothard
Journal:  mBio       Date:  2016-08-09       Impact factor: 7.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.